Jump to content

Cutibacterium acnes

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by TylerDurden8823 (talk | contribs) at 10:24, 18 June 2019 (Properly ordered refs.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Cutibacterium acnes
Scientific classification
Kingdom:
Bacteria
Phylum:
Actinobacteria
Order:
Actinomycetales
Family:
Propionibacteriaceae
Genus:
Cutibacterium[1]: 4429 
Species:
Cutibacterium acnes, C. acnes
Subspecies:
C. acnes subsp. acnes

C. acnes subsp. defendens

C. acnes subsp. elongatum[2]
Binomial name
Cutibacterium acnes
Scholz and Kilian, 2016[3][1]

Cutibacterium acnes (formerly Propionibacterium acnes)[1][2][3][4] is the relatively slow-growing, typically aerotolerant anaerobic, Gram-positive bacterium (rod) linked to the skin condition of acne;[5] it can also cause chronic blepharitis and endophthalmitis,[6] the latter particularly following intraocular surgery. Its genome has been sequenced and a study has shown several genes can generate enzymes for degrading skin and proteins that may be immunogenic (activating the immune system).[7]

The species is largely commensal and part of the skin flora present on most healthy adult humans' skin.[8] It is usually just barely detectable on the skin of healthy preadolescents. It lives, among other things, primarily on fatty acids in sebum secreted by sebaceous glands in the follicles. It may also be found throughout the gastrointestinal tract.[9]

Originally identified as Bacillus acnes,[10] it was later named Propionibacterium acnes for its ability to generate propionic acid.[11] In 2016, P. acnes was taxonomically reclassified as a result of biochemical and genomic studies. In terms of both phylogenetic tree structure and DNA G + C content, the cutaneous species was distinguishable from other species that had been previously categorized as P. acnes.[1][12] As part of restructuring, the novel genus Cutibacterium was created for the cutaneous species,[1] including those formerly identified as Propionibacterium acnes, Propionibacterium avidum, and Propionibacterium granulosum.[3] Characterization of phylotypes of C. acnes is an active field of research.[2][13][14]

Role in disease

C. acnes bacteria predominantly live deep within follicles and pores, although they are also found on the surface of healthy skin.[2] In these follicles, C. acnes bacteria use sebum, cellular debris and metabolic byproducts from the surrounding skin tissue as their primary sources of energy and nutrients. Elevated production of sebum by hyperactive sebaceous glands (sebaceous hyperplasia) or blockage of the follicle can cause C. acnes bacteria to grow and multiply.[15]

C. acnes bacteria secrete many proteins, including several digestive enzymes.[16] These enzymes are involved in the digestion of sebum and the acquisition of other nutrients. They can also destabilize the layers of cells that form the walls of the follicle. The cellular damage, metabolic byproducts and bacterial debris produced by the rapid growth of C. acnes in follicles can trigger inflammation.[17] This inflammation can lead to the symptoms associated with some common skin disorders, such as folliculitis and acne vulgaris.[18][19]

The damage caused by C. acnes and the associated inflammation make the affected tissue more susceptible to colonization by opportunistic bacteria, such as Staphylococcus aureus. Preliminary research shows healthy pores are only colonized by C. acnes, while unhealthy ones universally include the nonpore-resident Staphylococcus epidermidis, amongst other bacterial contaminants. Whether this is a root causality, just opportunistic and a side effect, or a more complex pathological duality between C. acnes and this particular Staphylococcus species is not known.[20]

C. acnes has also been found in corneal ulcers, and is a common cause of chronic endophthalmitis following cataract surgery. Rarely, it infects heart valves leading to endocarditis, and infections of joints (septic arthritis) have been reported.[9] Furthermore, Cutibacterium species have been found in ventriculostomy insertion sites, and areas subcutaneous to suture sites in patients who have undergone craniotomy. It is a common contaminant in blood and cerebrospinal fluid cultures.[21][22]

C. acnes has been found in herniated discs.[23] The propionic acid which it secretes creates micro-fractures of the surrounding bone. These micro-fractures are sensitive and it has been found that antibiotics have been helpful in resolving this type of low back pain.[24]

C. acnes can be found in bronchoalveolar lavage of approximately 70% of patients with sarcoidosis and is associated with disease activity, but it can be also found in 23% of controls.[25][26] The subspecies of C. acnes that cause these infections of otherwise sterile tissues (prior to medical procedures), however, are the same subspecies found on the skin of individuals who do not have acne-prone skin, so are likely local contaminants. Moderate to severe acne vulgaris appears to be more often associated with virulent strains.[27]

C. acnes is an opportunistic pathogen, causing a range of postoperative and device-related infections e.g., surgery,[28] post-neurosurgical infection,[29] joint prostheses, shunts and prosthetic heart valves. C. acnes may play a role in other conditions, including SAPHO (synovitis, acne, pustulosis, hyperostosis, osteitis) syndrome, sarcoidosis and sciatica.[30] It is also suspected a main bacterial source of neuroinflammation in Alzheimer's disease brains.[31]

Antimicrobial susceptibility

C. acnes bacteria are susceptible to a wide range of antimicrobial molecules, from both pharmaceutical and natural sources. Antibiotics are commonly used to treat infections caused by C. acnes. Acne vulgaris is the disease most commonly associated with C. acnes infection. The antibiotics most frequently used to treat acne vulgaris are erythromycin, clindamycin, doxycycline, and minocycline.[32][33][34] Several other families of antibiotics are also active against C. acnes bacteria, including quinolones, cephalosporins, pleuromutilins, penicillins, and sulfonamides.[35][36][37]

The emergence of antibiotic-resistant C. acnes bacteria represents a growing problem worldwide.[38] The problem is especially pronounced in North America and Europe.[39] The antibiotic families that C. acnes are most likely to acquire resistance to are the macrolides (e.g., erythromycin and azithromycin), lincosamides (e.g., clindamycin) and tetracyclines (e.g., doxycycline and minocycline).[40][41]

However, C. acnes bacteria are susceptible to many types of antimicrobial chemicals found in over-the-counter antibacterial products, including benzoyl peroxide,[42] triclosan,[43] chloroxylenol,[44] and chlorhexidine gluconate.[45]

Several naturally occurring molecules and compounds are toxic to C. acnes bacteria. Some essential oils such as rosemary,[46] tea tree oil,[47] clove oil,[48] and citrus oils[49][50] contain antibacterial chemicals.

The elements silver,[51] sulfur,[52] and copper[53] have also been demonstrated to be toxic towards many bacteria, including C. acnes. Natural honey has also been shown to have some antibacterial properties that may be active against C. acnes.[54]

Photosensitivity

C. acnes glows orange when exposed to blacklight, possibly due to the presence of endogenous porphyrins. It is also killed by ultraviolet light. C. acnes is especially sensitive to light in the 405–420 nanometer (near the ultraviolet) range due to an endogenic porphyrin–coporphyrin III. A total irradiance of 320 Joules/cm² inactivates this species in vitro.[55] Its photosensitivity can be enhanced by pretreatment with aminolevulinic acid, which boosts production of this chemical, although this causes significant side effects in humans, and in practice was not significantly better than the light treatment alone.[56][57]

Other habitats

C. acnes has been found to be an endophyte of plants. Notably, grapevine appears to host an endophytic population of C. acnes that is closely related to the human-associated strains. The two lines diverged roughly 7,000 years ago, at about the same time when grapevine agriculture may have been established. This C. acnes subtype was dubbed Zappae in honour of the eccentric composer Frank Zappa, to highlight its unexpected and unconventional habitat.[58]

References

  1. ^ a b c d e Scholz, Christian F. P.; Kilian, Mogens (1 November 2016). "The natural history of cutaneous propionibacteria, and reclassification of selected species within the genus Propionibacterium to the proposed novel genera Acidipropionibacterium gen. nov., Cutibacterium gen. nov. and Pseudopropionibacterium gen. nov" (PDF). International Journal of Systematic and Evolutionary Microbiology. 66 (11): 4422–4432. doi:10.1099/ijsem.0.001367. PMID 27488827. Retrieved 17 August 2018.
  2. ^ a b c d Dréno, B.; Pécastaings, S.; Corvec, S.; Veraldi, S.; Khammari, A.; Roques, C. (June 2018). "Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates". Journal of the European Academy of Dermatology and Venereology. 32: 5–14. doi:10.1111/jdv.15043. PMID 29894579.
  3. ^ a b c "Genus: Cutibacterium". Prokaryotic Nomenclature Up-to-Date. DSMZ. Retrieved 17 August 2018.
  4. ^ "Genus Cutibacterium". LPSN. Retrieved 17 August 2018.
  5. ^ Bhatia, Ajay; Maisonneuve, Jean-Francoise; Persing, David H. (2004-01-01). Proprionibacterium acnes and Chronic Diseases. National Academies Press (US).
  6. ^ Dali, P.; Giugliano, E. R.; Vellozzi, E. M.; Smith, M. A. (2001). "Susceptibilities of Propionibacterium acnes Ophthalmic Isolates to Moxifloxacin". Antimicrobial Agents and Chemotherapy. 45 (10): 2969–70. doi:10.1128/AAC.45.10.2969-2970.2001. PMC 90767. PMID 11583007.
  7. ^ Liu, J.; Cheng, A.; Bangayan, N.J.; Barnard, E.; Curd, E.; Craft, N.; Li, H. (2014). "Draft Genome Sequences of Propionibacterium acnes Type Strain ATCC6919 and Antibiotic-Resistant Strain HL411PA1". Genome Announcements. 2 (4): e00740–14. doi:10.1128/genomeA.00740-14. PMC 4132614. PMID 25125638. {{cite journal}}: Cite has empty unknown parameter: |month= (help)
  8. ^ Bruggemann, H.; Henne, A; Hoster, F; Liesegang, H; Wiezer, A; Strittmatter, A; Hujer, S; Dürre, P; Gottschalk, G (2004). "The Complete Genome Sequence of Propionibacterium Acnes, a Commensal of Human Skin". Science. 305 (5684): 671–3. Bibcode:2004Sci...305..671B. doi:10.1126/science.1100330. PMID 15286373.
  9. ^ a b Perry, Alexandra; Lambert, Peter (2011). "Propionibacterium acnes: Infection beyond the skin". Expert Review of Anti-infective Therapy. 9 (12): 1149–56. doi:10.1586/eri.11.137. PMID 22114965.
  10. ^ Gilchrist, T. C. (1900). "A bacteriological and microscopical study of over 300 vesicular and pustular lesions of the skin, with a research upon the etiology of acne vulgaris". Johns Hopkins Hospital Report. 9: 409–430.
  11. ^ Douglas, HC; Gunter, SE (July 1946). "The Taxonomic Position of Corynebacterium acnes" (PDF). Journal of Bacteriology. 52 (1): 15–23. PMID 16561149. Retrieved 17 August 2018.
  12. ^ "Propionibacterium Cutibacterium - late breaking news and a new name". Shoulder Arthritis / Rotator Cuff Tears: causes of shoulder pain. April 2, 2017. Retrieved 17 August 2018.
  13. ^ Dagnelie, M.-A.; Khammari, A.; Dréno, B.; Corvec, S. (March 2018). "Cutibacterium acnes molecular typing: time to standardize the method". Clinical Microbiology and Infection. doi:10.1016/j.cmi.2018.03.010. PMID 29544912. Retrieved 17 August 2018.
  14. ^ Zeller, Valérie A.; Letembet, Valérie-Anne; Meyssonnier, Vanina A.; Heym, Beate; Ziza, Jean-Marc; Marmor, Simon D. (July 2018). "Cutibacterium (Formerly Propionibacterium) avidum : A Rare but Avid Agent of Prosthetic Hip Infection". The Journal of Arthroplasty. 33 (7): 2246–2250. doi:10.1016/j.arth.2018.02.008. PMID 29544969. Retrieved 17 August 2018.
  15. ^ Makrantonaki (2011). "An update on the role of the sebaceous gland in the pathogenesis of acne". Dermatoendocrinology. 22 (5): 360–6. doi:10.1016/j.clindermatol.2004.03.004. PMID 15556719. {{cite journal}}: Unknown parameter |displayauthors= ignored (|display-authors= suggested) (help)
  16. ^ Holland, Carsten; Zimny-Arndt, Ursula; Schmid, Monika; Meyer, Thomas F; Jungblut, Peter R; Brüggemann, Holger (2010). "Proteomic identification of secreted proteins of Propionibacterium acnes". BMC Microbiology. 10: 230. doi:10.1186/1471-2180-10-230. PMC 3224659. PMID 20799957. {{cite journal}}: Unknown parameter |displayauthors= ignored (|display-authors= suggested) (help)CS1 maint: unflagged free DOI (link)
  17. ^ Kim, J (2005). "Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses". Dermatology. 211 (3): 193–198. doi:10.1159/000087011. PMID 16205063.
  18. ^ Zouboulis., Christos C. (2004). "Acne and sebaceous gland function". Clinics in Dermatology. 22 (5): 360–6. doi:10.1016/j.clindermatol.2004.03.004. PMID 15556719.
  19. ^ "Understanding Acne - News in Health, January 2010". Newsinhealth.nih.gov. Retrieved 2012-06-14.
  20. ^ Bek-Thomsen (2008). "Acne is Not Associated with Yet-Uncultured Bacteria". Journal of Clinical Microbiology. 20 (3): 197–203. PMID 14620162. {{cite journal}}: Unknown parameter |displayauthors= ignored (|display-authors= suggested) (help)
  21. ^ Portillo, María Eugenia; Corvec, Stéphane; Borens, Olivier; Trampuz, Andrej (2013). "An Underestimated Pathogen in Implant-Associated Infections". BioMed Research International. 2013: 1–10. doi:10.1155/2013/804391. PMC 3838805. PMID 24308006.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  22. ^ Gharamti, Amal A.; Kanafani, Zeina A. (17 November 2017). "Cutibacterium (formerly Propionibacterium) acnes infections associated with implantable devices". Expert Review of Anti-infective Therapy. 15 (12): 1083–1094. doi:10.1080/14787210.2017.1404452. PMID 29125405.
  23. ^ Capoor, Manu N.; Ruzicka, Filip; Schmitz, Jonathan E.; James, Garth A.; Machackova, Tana; Jancalek, Radim; Smrcka, Martin; Lipina, Radim; Ahmed, Fahad S. (2017-04-03). "Propionibacterium acnes biofilm is present in intervertebral discs of patients undergoing microdiscectomy". PLOS One. 12 (4): e0174518. Bibcode:2017PLoSO..1274518C. doi:10.1371/journal.pone.0174518. ISSN 1932-6203. PMC 5378350. PMID 28369127.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  24. ^ Albert (2013). "Antibiotic treatment in patients with chronic low back pain and vertebral bone edema (Modic type 1 changes): a double-blind randomized clinical controlled trial of efficacy". European Spine Journal. 22 (4): 697–707. doi:10.1007/s00586-013-2675-y. PMC 3631045. PMID 23404353. {{cite journal}}: Unknown parameter |displayauthors= ignored (|display-authors= suggested) (help)
  25. ^ Hiramatsu, J; Kataoka, M; Nakata, Y; Okazaki, K; Tada, S; Tanimoto, M; Eishi, Y (2003). "Propionibacterium acnes DNA detected in bronchoalveolar lavage cells from patients with sarcoidosis". Sarcoidosis, Vasculitis and Diffuse Lung Diseases. 20 (3): 197–203. PMID 14620162.
  26. ^ Inoue, Y; Suga, M (2008). "Granulomatous diseases and pathogenic microorganism". Kekkaku. 83 (2): 115–30. PMID 18326339.
  27. ^ Lomholt, Hans B.; Kilian, Mogens (2010). Bereswill, Stefan (ed.). "Population Genetic Analysis of Propionibacterium acnes Identifies a Subpopulation and Epidemic Clones Associated with Acne". PLoS ONE. 5 (8): e12277. Bibcode:2010PLoSO...512277L. doi:10.1371/journal.pone.0012277. PMC 2924382. PMID 20808860.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  28. ^ Haidar R., Najjar M., Boghossian A.D., Tabbarah Z., "Propionibacterium acnes causing delayed postoperative spine infection: Review." Scandinavian Journal of Infectious Diseases. 42 (6-7) (pp 405-411), 2010
  29. ^ Nisbet, M.; Briggs, S.; Ellis-Pegler, R.; Thomas, M. ;Holland, D. "Propionibacterium acnes: an under-appreciated cause of post-neurosurgical infection" Journal of Antimicrobial Chemotherapy. 60(5). NOV 2007. 1097-1103.1103..
  30. ^ Perry A., Lambert P. " Propionibacterium acnes: Infection beyond the skin." Expert Review of Anti-Infective Therapy. 9 (12) (pp 1149-1156), 2011
  31. ^ Emery, David C.; Shoemark, Deborah K. (2017). "16S rRNA Next Generation Sequencing Analysis Shows Bacteria in Alzheimer's Post-Mortem Brain". Frontiers in Aging Neuroscience. 9: 195. doi:10.3389/fnagi.2017.00195. PMC 5476743. PMID 28676754.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  32. ^ "Prescription Medications for Treating Acne". Skincarephysicians.com. 2007-02-16. Retrieved 2012-06-14.
  33. ^ The Cause Of Acne and Natural or Medical Acne Treatment
  34. ^ Strauss (2007). "Guidelines of care for acne vulgaris management". Journal of the American Academy of Dermatology. 56 (4): 651–63. doi:10.1016/j.jaad.2006.08.048. PMID 17276540. {{cite journal}}: Unknown parameter |displayauthors= ignored (|display-authors= suggested) (help)
  35. ^ Hoeffler (1976). "Antimicrobial Susceptibility of Propionibacterium acnes and related microbial species". Antimicrobial Agents and Chemotherapy. 10 (3): 387–94. doi:10.1128/aac.10.3.387. PMC 429758. PMID 984781. {{cite journal}}: Unknown parameter |displayauthors= ignored (|display-authors= suggested) (help)
  36. ^ Wang (1977). "Susceptibility of Propionibacterium acnes to seventeen antibiotics". Antimicrobial Agents and Chemotherapy. 11 (1): 171–3. doi:10.1128/aac.11.1.171. PMC 351938. PMID 836012. {{cite journal}}: Unknown parameter |displayauthors= ignored (|display-authors= suggested) (help)
  37. ^ "Antibiotic Susceptibility of Propionibacterium acnes". ScienceOfAcne.com. 2011-07-15. Retrieved 2012-08-08.
  38. ^ Tzellos (2011). "Treating acne with antibiotic-resistant bacterial colonization". Expert Opinion on Pharmacotherapy. 12 (8): 1233–47. doi:10.1517/14656566.2011.553192. PMID 21355786. {{cite journal}}: Unknown parameter |displayauthors= ignored (|display-authors= suggested) (help)
  39. ^ Ross (2001). "Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia". British Journal of Dermatology. 144 (2): 339–46. arXiv:1510.02343. doi:10.1046/j.1365-2133.2001.03956.x. hdl:10454/3311. PMID 11251569. {{cite journal}}: Unknown parameter |displayauthors= ignored (|display-authors= suggested) (help)
  40. ^ Ross (2003). "Antibiotic-resistant acne: lessons from Europe". British Journal of Dermatology. 148 (3): 467–78. doi:10.1046/j.1365-2133.2003.05067.x. hdl:10454/3069. PMID 12653738. {{cite journal}}: Unknown parameter |displayauthors= ignored (|display-authors= suggested) (help)
  41. ^ Coates (2002). "Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study". British Journal of Dermatology. 146 (5): 840–8. doi:10.1046/j.1365-2133.2002.04690.x. PMID 12000382. {{cite journal}}: Unknown parameter |displayauthors= ignored (|display-authors= suggested) (help)
  42. ^ Leyden, JJ; Wortzman, M; Baldwin, EK (2008). "Antibiotic-resistant Propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6%". Cutis. 82 (6): 417–21. PMID 19181031.
  43. ^ "Q&A for Health Care Professionals: Health Care Antiseptics". U.S. Food and Drug Administration. December 19, 2017. Retrieved 17 August 2018.
  44. ^ Emsley, John (July 1, 2004). Vanity, Vitality, and Virility: The Chemistry Behind the Products You Love to Buy. Oxford University. ISBN 978-0-19-280509-6. Retrieved 17 August 2018.
  45. ^ Shimizu, Tadamichi; Yamakoshi; Makino; Matsunaga; Yoshihisa; Rehman; Seki; Hayashi (July 2012). "Efficacy of chlorhexidine gluconate ointment (Oronine H®) for experimentally-induced comedones". Clinical, Cosmetic and Investigational Dermatology. 5: 79–83. doi:10.2147/CCID.S33361. PMC 3426266. PMID 22936850.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  46. ^ Fu, Yujie; Zu, Yuangang; Chen, Liyan [Author]; Efferth, Thomas; Liang, Huili; Liu, Zhiguo; Liu, Wei "Investigation of antibacterial activity of rosemary essential oil against propionibacterium acnes with atomic force microscopy"Planta Medica. 73(12). Oct 2007. 1275-1280.
  47. ^ Raman (1995). "Antimicrobial effects of tea-tree oil and its major components on Staphylococcus aureus, Staph. epidermidis and Propionibacterium acnes". Letters in Applied Microbiology. 21 (4): 242–5. doi:10.1111/j.1472-765x.1995.tb01051.x. PMID 7576514. {{cite journal}}: Unknown parameter |displayauthors= ignored (|display-authors= suggested) (help)
  48. ^ Fu, Yujie; Chen, L; Zu, Y; Liu, Z; Liu, X; Liu, Y; Yao, L; Efferth, T (2009). "The Antibacterial Activity of Clove Essential Oil Against Propionibacterium acnes and Its Mechanism of Action". Archives of Dermatology. 145 (1): 86–8. doi:10.1001/archdermatol.2008.549. PMID 19153353.
  49. ^ Lang, Gudrun Buchbauer, Gerhard "A review on recent research results (2008–2010) on essential oils as antimicrobials and antifungals. A review." Flavour and Fragrance Journal 271 2012
  50. ^ Baik, Jong Seok [Author]; Kim, Sang-Suk [Author]; Lee, Jung-A [Author]; Oh, Tae-Heon [Author]; Kim, Ji-Young [Author]; Lee, Nam Ho [Author]; Hyun, Chang-Gu "Chemical composition and biological activities of essential oils extracted from Korean endemic citrus species" Journal of Microbiology & Biotechnology. 18(1). JAN 2008. 74-79.
  51. ^ Bayston (2010). "In vitro antimicrobial activity of silver-processed catheters for neurosurgery". Journal of Antimicrobial Chemotherapy. 65 (2): 258–65. doi:10.1093/jac/dkp420. PMID 19942617. {{cite journal}}: Unknown parameter |displayauthors= ignored (|display-authors= suggested) (help)
  52. ^ Libenson (1953). "Antibacterial effect of elemental sulfur". Journal of Infectious Diseases. 93 (1): 28–35. doi:10.1093/infdis/93.1.28. PMID 13069766. {{cite journal}}: Unknown parameter |displayauthors= ignored (|display-authors= suggested) (help)
  53. ^ McLean (1993). "Antibacterial activity of multilayer silver-copper surface films on catheter material". Canadian Journal of Microbiology. 39 (9): 895–9. doi:10.1139/m93-134. PMID 8242490. {{cite journal}}: Unknown parameter |displayauthors= ignored (|display-authors= suggested) (help)
  54. ^ Albietz (2006). "Effect of antibacterial honey on the ocular flora in tear deficiency and meibomian gland disease". Cornea. 25 (9): 1012–9. doi:10.1097/01.ico.0000225716.85382.7b. PMID 17133045. {{cite journal}}: Unknown parameter |displayauthors= ignored (|display-authors= suggested) (help)
  55. ^ Papageorgiou, P.; Katsambas, A.; Chu, A. (2000). "Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris". British Journal of Dermatology. 142 (5): 973–8. doi:10.1046/j.1365-2133.2000.03481.x. PMID 10809858.
  56. ^ Togsverd-Bo, K; Wiegell, SR; Wulf, HC; Haedersdal, M (February 2009). "Short and limited effect of long-pulsed dye laser alone and in combination with photodynamic therapy for inflammatory rosacea". Journal of the European Academy of Dermatology and Venereology. 23 (2): 200–201. doi:10.1111/j.1468-3083.2008.02781.x. PMID 18452529.
  57. ^ Lin, Jennifer; Wan, Marilyn T. (May 2014). "Current evidence and applications of photodynamic therapy in dermatology". Clinical, Cosmetic and Investigational Dermatology. 7: 145–163. doi:10.2147/CCID.S35334. PMC 4038525. PMID 24899818.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  58. ^ Campisano, A.; Ometto, L.; Compant, S. (2014). "Interkingdom transfer of the acne causing agent, Propionibacterium acnes, from human to grapevine". Molecular Biology and Evolution. 31 (5): 1059–65. doi:10.1093/molbev/msu075. PMID 24554779.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Cutibacterium_acnes&oldid=902368692"